Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version-Reference-Cited by-同舟云学术

Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version

Published:2016-02-26 Issue:1 Volume:54 Page:65-70
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Ostovan Vahid Reza¹,Fatehi Farzad¹,Davoudi Farnoush²,Nafissi Shahriar¹

Affiliation:

1. Iranian Center of Neurological Research, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences; North Kargar Street; Tehran Iran 14117-13135

2. Department of Community Medicine; Iran University of Medical sciences; Tehran Iran

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.25002/fullpdf

Reference23 articles.

2. Quality of life and well-being of patients with myasthenia gravis;Paul;Muscle Nerve,2001

3. Measuring quality of life today: methodological aspects;Cella;Oncology (Williston Park),1990

4. History of outcome measures for myasthenia gravis;Burns;Muscle Nerve,2010

5. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America;Jaretzki;Neurology,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Myasthenia Gravis Quality of Life Revised 15 (MGQOL15r) Scale in India;Annals of Indian Academy of Neurology;2023

2. Validation of myasthenia gravis activity of daily living questionnaire: Persian version;Current Journal of Neurology;2022-05-01

3. Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar;Frontiers in Neurology;2021-08-26

4. Validation of Spanish version of 15‐item myasthenia gravis quality‐of‐life questionnaire;Acta Neurologica Scandinavica;2021-06-15

5. Health‐related quality of life and treatment strategies in myasthenia gravis;Clinical and Experimental Neuroimmunology;2020-10-05